51 related articles for article (PubMed ID: 34624670)
1. Increasing anticancer effect in vitro and vivo of liposome-encapsulated iridium(III) complexes on BEL-7402 cells.
Zhang Y; Fei W; Zhang H; Zhou Y; Tian L; Hao J; Yuan Y; Li W; Liu Y
J Inorg Biochem; 2021 Dec; 225():111622. PubMed ID: 34624670
[TBL] [Abstract][Full Text] [Related]
2. Iridium(III)-BBIP complexes induce apoptosis via PI3K/AKT/mTOR pathway and inhibit A549 lung tumor growth in vivo.
Zhou Y; Bai L; Tian L; Yang L; Zhang H; Zhang Y; Hao J; Gu Y; Liu Y
J Inorg Biochem; 2021 Oct; 223():111550. PubMed ID: 34311319
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and mitochondria-localized iridium (III) complexes induce cell death through pyroptosis and ferroptosis pathways.
Hu H; Zhang F; Sheng Z; Tian S; Li G; Tang S; Niu Y; Yang J; Liu Y
Eur J Med Chem; 2024 Mar; 268():116295. PubMed ID: 38437750
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization and irradiation enhances anticancer activity of liposome-loaded iridium(III) complexes.
Tian S; Nie Q; Chen H; Liang L; Hu H; Tang S; Yang J; Liu Y; Yin H
J Inorg Biochem; 2024 Jul; 256():112549. PubMed ID: 38579631
[TBL] [Abstract][Full Text] [Related]
5. Targeted liposomes encapsulated iridium(III) compound greatly enhance anticancer efficacy and induce cell death via ferroptosis on HepG2 cells.
Chen J; Li W; Li G; Liu X; Huang C; Nie H; Liang L; Wang Y; Liu Y
Eur J Med Chem; 2024 Feb; 265():116078. PubMed ID: 38141286
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria-targeted iridium(III) complexes encapsulated in liposome induce cell death through ferroptosis and gasdermin-mediated pyroptosis.
Huang C; Yuan Y; Li G; Tian S; Hu H; Chen J; Liang L; Wang Y; Liu Y
Eur J Med Chem; 2024 Feb; 265():116112. PubMed ID: 38183779
[TBL] [Abstract][Full Text] [Related]
7. Iridium(III) complex induces apoptosis in HeLa cells by regulating mitochondrial and PI3K/AKT signaling pathways: In vitro and in vivo experiments.
He SF; Han WC; Shao YY; Zhang HB; Hong WX; Yang QH; Zhang YQ; He RR; Sun J
Bioorg Chem; 2023 Dec; 141():106867. PubMed ID: 37734195
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria-targeted cyclometalated iridium (III) complexes: Dual induction of A549 cells apoptosis and autophagy.
Chen L; Tang H; Chen W; Wang J; Zhang S; Gao J; Chen Y; Zhu X; Huang Z; Chen J
J Inorg Biochem; 2023 Dec; 249():112397. PubMed ID: 37844533
[TBL] [Abstract][Full Text] [Related]
9. Iridium(III) complexes conjugated with naproxen exhibit potent anti-tumor activities by inducing mitochondrial damage, modulating inflammation, and enhancing immunity.
Xie K; Lu XY; Zhu H; Zhu LY; Li RT; Ye RR
Dalton Trans; 2024 May; 53(20):8772-8780. PubMed ID: 38712840
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of mixed-ligand cyclometalated iridium(III)-quinoline complexes.
Yang Y; Wang CM; Pan FH; Qin QP; Xie QJ; Chen Q; Liang H
Dalton Trans; 2021 Nov; 50(44):16273-16280. PubMed ID: 34730150
[TBL] [Abstract][Full Text] [Related]
11. Dual inhibition of oxidative phosphorylation and glycolysis to enhance cancer therapy.
Sheng X; Wang MM; Zhang GD; Su Y; Fang HB; Yu ZH; Su Z
Bioorg Chem; 2024 Jun; 147():107325. PubMed ID: 38583247
[TBL] [Abstract][Full Text] [Related]
12. Photoactivatable, mitochondria targeting dppz iridium(III) complex selectively interacts and damages mitochondrial DNA in cancer cells.
Kasparkova J; Novohradsky V; Ruiz J; Brabec V
Chem Biol Interact; 2024 Apr; 392():110921. PubMed ID: 38382705
[TBL] [Abstract][Full Text] [Related]
13. Study on the Multimodal Anticancer Mechanism of Ru(II)/Ir(III) Complexes Bearing a Poly(ADP-ribose) Polymerase 1 Inhibitor.
Yang Y; Gao Y; Sun Y; Zhao J; Gou S
J Med Chem; 2023 Oct; 66(19):13731-13745. PubMed ID: 37788351
[TBL] [Abstract][Full Text] [Related]
14. The anticancer application of half-sandwich iridium(III) ferrocene-thiosemicarbazide Schiff base complexes.
Liu X; Lv A; Zhang P; Chang J; Dong R; Liu M; Liu J; Huang X; Yuan XA; Liu Z
Dalton Trans; 2024 Jan; 53(2):552-563. PubMed ID: 38054240
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, and Activity Evaluation of Novel Acyclic Nucleosides as Potential Anticancer Agents
Hao EJ; Li GX; Liang YR; Xie MS; Wang DC; Jiang XH; Cheng JY; Shi ZX; Wang Y; Guo HM
J Med Chem; 2021 Feb; 64(4):2077-2109. PubMed ID: 33538581
[TBL] [Abstract][Full Text] [Related]
16. Development of Cu(II) 4-hydroxybenzoylhydrazone complexes that induce mitochondrial DNA damage and mitochondria-mediated apoptosis in liver cancer.
Jiang M; Yan Q; Fu Y; Meng L; Gai S; Pan X; Qin Y; Jiang C
J Inorg Biochem; 2024 Jul; 256():112550. PubMed ID: 38599004
[TBL] [Abstract][Full Text] [Related]
17. Potent Half-Sandwich 16-/18-Electron Iridium(III) and Ruthenium(II) Anticancer Complexes with Readily Available Amine-Imine Ligands.
Guo L; Li P; Li J; Gong Y; Li X; Wen T; Wu X; Yang X; Liu Z
Inorg Chem; 2023 Dec; 62(51):21379-21395. PubMed ID: 38096360
[TBL] [Abstract][Full Text] [Related]
18. In Vitro Anticancer Activity and in Vivo Biodistribution of Rhenium(I) Tricarbonyl Aqua Complexes.
Knopf KM; Murphy BL; MacMillan SN; Baskin JM; Barr MP; Boros E; Wilson JJ
J Am Chem Soc; 2017 Oct; 139(40):14302-14314. PubMed ID: 28948792
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria-targeted neutral and cationic iridium(III) anticancer complexes chelating simple hybrid sp
Li P; Guo L; Li J; Yang Z; Fu H; Lai K; Dong H; Fan C; Liu Z
Dalton Trans; 2024 Jan; 53(5):1977-1988. PubMed ID: 38205595
[TBL] [Abstract][Full Text] [Related]
20. Cyclometalated Iridium(III) Complexes as AIE Phosphorescent Probes for Real-Time Monitoring of Mitophagy in Living Cells.
Jin C; Liu J; Chen Y; Guan R; Ouyang C; Zhu Y; Ji L; Chao H
Sci Rep; 2016 Feb; 6():22039. PubMed ID: 26907559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
